13F Data
13F filer · CIK 1595851

Ghost Tree Capital, LLC

NEW YORK, NY · filing since Q4 2013 · last filing Nov 14, 2024
Reported value
$331.0M
+$11.7M vs prior
Positions
54
New / sold out
12 / 21
Added / reduced
16 / 23
Turnover
38.8%
buys $126.2M · sells $146.4M
Top-10 weight
42.4%

Biggest buys vs Q2 2024

ChangeSecurityShares changeChange %Est. trade value
NewSPDR SER TRPUT+300,000–+$29.6M
NewBIOHAVEN LTD+348,778–+$17.4M
NewNOVO-NORDISK A S+110,000–+$13.1M
AddedBLUEPRINT MEDICINES CORP+100,000+250.0%+$9.3M
AddedSAREPTA THERAPEUTICS INC+65,000+118.2%+$8.1M
AddedJANUX THERAPEUTICS INC+140,000+280.0%+$6.4M
NewEDGEWISE THERAPEUTICS INC+195,000–+$5.2M
NewCORBUS PHARMACEUTICALS HLDGSPUT+220,000–+$4.5M
AddedTARSUS PHARMACEUTICALS INC+115,000+48.9%+$3.8M
NewDYNE THERAPEUTICS INC+100,000–+$3.6M
18 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Biggest sells vs Q2 2024

ChangeSecurityShares changeChange %Est. trade value
Sold outBIOHAVEN LTD-490,000-100.0%$-17.0M
Sold outALNYLAM PHARMACEUTICALS INCPUT-68,400-100.0%$-16.6M
ReducedVIRIDIAN THERAPEUTICS INC-512,708-87.2%$-11.7M
ReducedINSMED INCCALL-150,000-75.0%$-10.9M
ReducedMOONLAKE IMMUNOTHERAPEUTICS-171,589-57.2%$-8.7M
ReducedVAXCYTE INC-70,000-46.7%$-8.0M
ReducedSOLENO THERAPEUTICS INC-150,000-50.0%$-7.6M
ReducedSPYRE THERAPEUTICS INC-190,237-76.0%$-5.6M
Sold outALNYLAM PHARMACEUTICALS INC-22,500-100.0%$-5.5M
ReducedASCENDIS PHARMA A/S-34,221-39.5%$-5.1M
34 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2013: $162.5MQ1 2014: $168.4MQ2 2014: $141.8MQ3 2014: $184.2MQ4 2014: $208.4MQ1 2015: $278.1MQ2 2015: $308.6MQ3 2015: $222.2MQ4 2015: $244.2MQ1 2016: $176.7MQ2 2016: $346.3MQ3 2016: $616.6MQ4 2016: $415.5MQ1 2017: $536.5MQ2 2017: $481.1MQ3 2017: $470.9MQ4 2017: $426.4MQ1 2018: $377.3MQ2 2018: $339.8MQ3 2018: $470.5MQ4 2018: $275.5MQ1 2019: $382.8MQ2 2019: $482.1MQ3 2019: $392.5MQ4 2019: $525.1MQ1 2020: $377.0MQ2 2020: $379.0MQ3 2020: $346.0MQ4 2020: $448.8MQ1 2021: $425.5MQ2 2021: $363.8MQ3 2021: $342.0MQ4 2021: $279.0MQ1 2022: $460.8MQ2 2022: $192.0MQ3 2022: $356.3MQ4 2022: $234.2MQ1 2023: $338.3MQ2 2023: $302.9MQ3 2023: $304.1MQ4 2023: $305.9MQ1 2024: $361.3MQ2 2024: $319.3MQ3 2024: $331.0M
Q4 2013Q3 2024

Holdings · Q3 2024

#SecuritySharesValueWeight
1SPDR SER TRPUTS&P BIOTECH300,000$29.6M8.95%
2BIOHAVEN LTDCALL348,778$17.4M5.26%
3SAREPTA THERAPEUTICS INCCOM120,000$15.0M4.53%
4NOVO-NORDISK A SADR110,000$13.1M3.96%
5BLUEPRINT MEDICINES CORPCOM140,000$12.9M3.91%
6AXSOME THERAPEUTICS INCCOM135,000$12.1M3.66%
7TARSUS PHARMACEUTICALS INCCOM350,000$11.5M3.48%
8PERSPECTIVE THERAPEUTICS INCCOM NEW750,000$10.0M3.02%
9CG ONCOLOGY INCCOM250,000$9.4M2.85%
10ROIVANT SCIENCES LTDSHS800,000$9.2M2.79%
44 more rows. Subscribe for $29/month to see every row, download the data and use the API.